Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Country / region: Japan Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20151
20181
20192
20205
20212
20221
20232
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting4
Recruiting4
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx5
Takeda4
Novartis Pharmaceuticals3
Chugai Pharmaceutical2
GlaxoSmithKline2
UCB Biopharma SRL2
Kissei Pharmaceutical Co., Ltd.1
Principia Biopharma, a Sanofi Company1
Sanofi1
Sobi, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic22
Hemorrhage3
Antiphospholipid Syndrome2
Autoimmune Diseases2
Behcet Syndrome2
Blood Platelet Disorders2
Cytopenia2
Dermatomyositis2
Hematologic Diseases2
Hemorrhagic Disorders2

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.